The structure of chromatin, which influences numerous DNA-associated phenomena, such as transcription, replication, recombination and repair, is controlled by a complex combination of histone modifications, ATPdependent chromatin-remodeling enzymes, and nucleosome-assembly factors. The modification of histones occurs at their N-terminal tails, which can be modified by acetylation, phosphorylation, methylation, ubiquitination, sumoylation, and ADP-ribosylation [1, 2] . Transcription factor Jun dimerization protein 2 (JDP2) binds directly to histones and DNA, and inhibits p300-mediated acetylation of core histones and reconstituted nucleosomes that contain JDP2-recognition DNA sequences. The region of JDP2 that encompasses its histone-binding domain and DNA-binding region is essential to inhibit histone acetylation by histone acetyltransferases. Moreover, assays of nucleosome assembly in vitro demonstrate that JDP2 also has histone-chaperone activity. The mutation of the region responsible for inhibition of histone acetyltransferase activity within JDP2 eliminates repression of transcription from the c-jun promoter by JDP2, as well as JDP2-mediated inhibition of retinoic-acid-induced differentiation. Thus JDP2 plays a key role as a repressor of cell differentiation by regulating the expression of genes with an activator protein 1 (AP-1) site via inhibition of histone acetylation and/or assembly and disassembly of nucleosomes. Senescent cells show a series of alterations, including flatten and enlarged morphology, increase in nonspecific acidic β-galactosidase activity, chromatin condensation, and changes in gene expression patterns. The onset and maintenance of senescence are regulated by two tumor suppressors, p53 and retinoblastoma proteins. The expression of p53 and retinoblastoma proteins is regulated by two distinct proteins, p16 Ink4a and Arf, respectively, which are encoded by cdkn2a. JDP2 inhibits recruitment of the polycomb repressive complexes 1 and 2 (PRC-1 and PRC-2) to the promoter of the gene that encodes p16
Among these modifications, the acetylation of histones occurs at highest frequency and has been studied most extensively, with the resultant identification of a number of histone acetyltransferases (HATs) and histone deacetylases (HDACs), together with their target lysine residues within specific histones in the chromatin. The activities of HATs are not only antagonized by HDACs but are also regulated by cellular and viral regulatory factors that include histone chaperones and enzymes that catalyze posttranslational modification [3, 4] .
Chromatin consists of structural units known as nucleosomes. Each nucleosome consists of two histone H2A-H2B dimers, a histone (H3-H4) 2 tetramer, and DNA that is wrapped around the resultant histone octamers. During chromatin assembly, a histone (H3-H4) 2 tetramer is formed before the two heterodimers H2A and H2B are incorporated to form a nucleosome [5, 6] . Regulation of transcription is associated with alterations in chromatin structure that include histone modifications and changes in nucleosome structure [7] [8] [9] [10] . Compaction of the chromatin and organization of nucleosomes represent a barrier that has to be overcome prior to activation of transcription. The N-terminal histone tails that protrude from the nucleosomes do not play a significant role in nucleosome formation, but they appear to act as docking sites for other proteins and protein complexes to regulate chromatin compaction [9] .
The structure of chromatin changes to allow greater accessibility by transcription factors when a gene is to be activated [9] . It has been suggested that the change to a more accessible state not only involves the modification of histones and alterations in nucleosomal arrays, but also results from changes in nucleosome integrity that are due to displacement of histones [11] . Furthermore, it has been demonstrated that histone chaperones play a critical role in these processes [12] [13] [14] [15] . Thus it is tempting to speculate that histone chaperones might be important for the compaction of chromatin, and it is now important to determine whether certain co-repressors of transcription might influence the deposition and assembly of nucleosomes via regulation of histone-chaperone activity.
Primary cultures of untransformed cells stop growing after several weeks and undergo senescence, a phenomenon that is related to so-called cellular aging. Senescence protects normal cells from abnormal growth signals and oncogenic transformation, and impairs their reprogramming to pluripotent stem cells [16] by interrupting the cell cycle. Senescence is induced not only by cellular aging, but also by the forced activation of the mitogen-activated protein (MAP) kinase pathway and by genotoxic stressors, such as hydrogen peroxide and certain DNA-damaging compounds. Senescence increases the activities of two wellknown tumor suppressors, retinoblastoma protein (Rb) and p53 protein. The expression of Rb and p53 is regulated by two distinct proteins, p16
Ink4a and Arf, respectively, which are encoded by the cdkn2a locus [17] . The expression of p16 Ink4a increases dramatically with increasing numbers of cell divisions in primary fibroblasts in culture, and in rodent and human models in vivo. In this review, we summarize the roles of p16 Ink4a and Arf in the cell cycle, and describe a novel mechanism for the regulation of their expression.
P16

INK4A AND THE RB PATHWAY
Genes that are essential for cell-cycle progression are transcribed at the beginning of G1 phase by the E2F family of transcription factors. E2F is controlled by the Rb family of proteins, pRb, p107, and p130 [18, 19] . Early in G1, unphosphorylated Rb proteins bind to the E2F family of proteins and inactivate their function [20, 21] . During G1, the Rb proteins are inactivated by phosphorylation by cyclin dependent kinase 4/6 (Cdk4/6)-cyclin D complexes, thereby allowing the transcription of E2F-dependent genes, including cyclin E. Upregulated cyclin E forms a complex with cdk2 that mediates the hyperphosphorylation of the Rb proteins, which is an essential requirement for G1/S transition. p16 Ink4a is an allosteric inhibitor of cdk4/6. Binding to p16 Ink4a changes the conformations of cdk4/6, which prevents its interaction with cyclin D [22, 23] . Therefore, p16 Ink4a acts as an inhibitor of the cell cycle at G1 by modulating the Rb pathway. p16 Ink4a is often lost in a variety of human malignancies, including glioblastoma, melanoma, and pancreatic adenocarcinoma [24] . In contrast, the upregulation of p16
Ink4a induces cell-cycle arrest and senescence [23, 24] .
ARF AND THE P53 PATHWAY
p53 is known to mediate cell-cycle arrest in G1 and G2, and apoptosis. A number of downstream targets of p53 are involved in these processes, including p21 Cip/waf1 in G1 arrest [25] , 14-3-3 sigma and growth arrest and DNA damage inducer gene 45 (GADD45) in G2 arrest [26, 27] , and p21, Bax, PI-3 up-regulation modulator of apoptosis (PUMA), Fas/Apo1, and Killer/DR5 in apoptosis [28] [29] [30] [31] [32] . p53 is regulated at the levels of protein stability and activity, and to some extent at transcription and translation [33, 34] . In unstressed cells, p53 protein levels are very low because its degradation is mediated by the E3 ubiquitin ligase activity of murine double minute 2 (MDM2), which targets p53 for ubiquitin-dependent proteolysis [35] . MDM2 is a transcriptional target of p53, therefore, p53 directly activates expression of its own negative regulator, which produces a potent negative feedback regulatory loop [36] . There are several stress-responsive kinases, which, by phosphorylating p53, inhibit p53 degradation by MDM2 and increase its transcriptional activity [37] [38] [39] . DNA damage rapidly activates the ataxia telangiectasia mutated and ataxia telangiectasia related proteins, which phosphorylate the checkpoint kinases 1 and 2 (Chk1 and Chk2), which in turn propagate the signal to downstream effectors such as p53 [40, 41] . Chk1 and Chk2 phosphorylate p53 at Ser 20, which prevents the efficient recruitment of MDM2. Thus p53 is stabilized and its expression level is increased in response to stress signaling. Arf is predominantly localized in the nucleoli and is stabilized by binding to nucleophosmin. In response to stress signaling, Arf is released from nucleophosmin and translocates to the nucleoplasm, where it interacts with MDM2, inhibits its E3 ubiquitin ligase activity, and blocks the nucleocytoplasmic shuttling of the MDM2-p53 complex. Therefore, the consequences of the activation of Arf are stabilization and activation of p53 [42, 43] .
TRANSCRIPTIONAL REGULATION OF P16
INK4A
The transcriptional regulation of the p16 Ink4a gene is an important event in cellular senescence. Expression of p16 Ink4a is increased during replicative senescence and in the premature senescence induced by oncogenic activation. Its expression is regulated by transcriptional activators such as Ets1/2 and the basic helix-loop-helix (b-HLH) protein E47, as well as by transcriptional inhibitors including the Id-1 HLH protein [44] [45] [46] [47] . The p16 Ink4a locus is also epigenetically repressed by the polycomb repressive complexes 1 and 2 (PCR-1 and PCR-2, respectively), which methylate lysine 27 of histone H3 (H3K27) [48] . In transformed cells, in which the cell cycle is not arrested by a senescence program, the CpG islands in the p16 Ink4a promoter and exon 1 are methylated and the p16 Ink4a gene is silenced [49, 50] .
Understanding the role of all the factors that regulate the expression of p16
Ink4a is important in clarifying the molecular mechanism of cellular aging. We describe here some of these factors, including transcriptional activators and inhibitors, and epigenetic regulators.
Transcriptional activators
Both Ets1 and Ets2 activate p16 Ink4a expression through activation of the Ras-MEK-MAP kinase pathway by directly binding to the ETS consensus sites in its promoter [47] . In human fibroblasts, the hyperactivation of Ets2 by overexpression of the Ras oncogene induces G1 arrest, premature senescence, and increased expression of p16 Ink4a . Ets2 seems to be the main regulator of p16 Ink4a expression during oncogenic premature senescence, whereas Ets1 plays a role in replicative senescence [51, 52] . The basic helix-loop-helix (b-HLH) protein E47 binds to DNA and proteins through its basic and HLH domains, respectively. The E47 homodimer binds specifically to the E box (CANNTG) in the p16 Ink4a promoter [46] . Overexpression of E47 inhibits the proliferation of some tumor cell lines by inducing expression of p16
Ink4a
. Inhibition of E47 by RNA interference significantly reduces expression of p16
and delays the onset of senescence [44] . Similarly, the heterodimerization of E47 with ectopically expressed Tal1 inhibits expression of p16
Ink4a [53] .
Transcriptional inhibitors
The expression of inhibition of differentiation protein-1 (Id-1) correlates negatively with p16 Ink4a expression during the process of senescence [44, 47] . [48, 59] . In PRC2, Ezh2 is the catalytic subunit that methylates H3K27 [48] , whereas the other components are indispensible for the function of the complex. Suz12 is essential for complex formation and di-and trimethylation of H3K27 in vivo [60, 61] . In contrast, Eed is required for global H3K27 methylation, including its monomethylation [62] . PRC1, the CBX subunit recognizes and binds to trimethylated H3K27 [63, 64] . Ring1B has E3 ligase activity for the ubiquitylation of histone H2A, whereas Bmi1 acts as a cofactor [65, 66] . Ubiquitylation of H2A by PRC1 prevents transcript elongation by RNA polymerase II [67] . PRC1 has been shown by electron microscopy to contribute to chromatin compaction [68] . Therefore, a possible molecular mechanism of PRC-mediated gene silencing might involve trimethylation of histone H3K27 by Ezh2 and the other subunits of PRC2. Then, this acts as a binding site for PRC1, which ubiquitylates H2A and compacts the chromatin, and leads to inhibition of transcript elongation by RNA polymerase II.
PRCs might also inhibit earlier steps in transcription, because PRC1 interacts with components of the basal transcription machinery, the TATA-box-binding protein-associated factors [69, 70] . This inhibition does not appear to involve blocking the access of RNA polymerase to the promoter, because the PRCs and transcription factors bind to the target genes at the same time [68, [70] [71] [72] [73] . In summary, p16
Ink4a transcription is inhibited by PRC2, which methylates histone H3K27, which in turn recruits PRC1. PRC1 represses p16 An important aim is to understand how the H3K27 trimethylation signal is lost in senescent cells. The possible explanations are as follows: (1) the action of as-yetunidentified histone demethylases and/or inhibitors of the methyl transferases involved in H3K27 trimethylation; or (2) histone chaperones recruit histone variants to the chromatin to alter gene expression. A recent study has shown that the H3K27-specific demethylase, Junonji domain-containing protein 3 (JMJD3) is induced by Ras-Raf signaling, as well as by environmental stresses. JMJD3 is recruited to the p16 Ink4a locus and contributes to the transcriptional activation of p16 Ink4a [74, 75] . We propose that senescence is regulated by Jun dimerization protein 2 (JDP2) of p16
Ink4a , which has histone-binding and chaperone activities [74, 75] . JDP2 is a member of the activator protein 1 (AP1) family of transcription factors, and activates the transcription of p16
Ink4a , as described below [76] .
REGULATION OF ARF
The contribution of Arf to senescence is still controversial. In general, it seems that p16 Ink4a plays a central role in senescence and tumor suppression in human cells, whereas Arf has a relatively more prominent role in mouse cells. In human cells, mutations are specifically found in p16
Ink4a
, rather than in Arf. Mutations of p16
Ink4a are frequently observed in primary cancers, and occur during the establishment of immortal cell lines [24, 77] . Signaling by the Ras oncogene and telomere shortening also induce p53-and Arf-independent growth arrest [78, 79] . In contrast, in MEFs, expression of Arf correlates with the onset of senescence, and cells that lack Arf do not become senescent in culture [80, 81] . Mouse strains with targeted deletions in p16 Ink4a or
Arf are tumor prone, whereas animals that lack p16
and Arf have a more severe phenotype [53, [81] [82] [83] [84] .
Signaling from oncogenic Ras activates transcription of the cyclin-D-binding Myb-like protein 1 gene (Dmp1) via the MAP kinase pathway and AP1 transcription factors, such as c-Jun and Jun-B. DMP1 binds to and activates transcription of the Arf promoter [85] . This pathway is important, because oncogenic Ras fails to activate Arf in MEFs from Dmp1-null mice [86] . Curiously, factors that activate Arf expression can have different phenotypic effects: Ras induces senescence, whereas Myc induces apoptosis. The overexpression of Myc in B lymphocytes augments cell proliferation, which is counteracted by the Arf-p53-MDM2 pathway. Suppression of this pathway inhibits Myc-induced apoptosis and facilitates formation of B-cell lymphoma [87] . However, another study has shown that induction of Arf requires high and continuous Myc activity, and that physiological levels of Myc are insufficient to stimulate the Arf promoter [88] .
E2F TRANSCRIPTION FACTORS ACTIVATE THE ARF PROMOTER
E2F1 stimulates expression of Arf and activates the Arf-p53-p21 WAF1 axis, which blocks cell proliferation.
This block is removed by the loss of function of the Arf-MDM2-p53 pathway, which results in E2F1-induced S-phase entry [89] . E2F family members bind directly to the Arf promoter, as shown by chromatin immunoprecipitation assay [90] [91] [92] . Ectopic expression of E2F1, E2F2 and E2F3 activates the Arf promoter in human cells [90) ] In contrast, an isoform of E2F3, E2F3b, represses the Arf promoter in MEFs [91] . Among the AP1 family of transcription factors, the c-Jun-and Fos-related antigen-1 (Fra1) heterodimer is an activator of Arf transcription in human and mouse cells. The knockdown of Fos-related antigen-1 in human cells or a deficiency of c-Jun in MEFs results in reduced expression of Arf [93] . In contrast, JunD seems to be a repressor of Arf, because MEFs that lack JunD express elevated levels of Arf, and display p53-dependent growth arrest and premature senescence [94] . Arf is also repressed transcriptionally by early growth response protein 1 (Egr1) and Zbtb7a (pokemon). Egr1-null MEFs express increased levels of Arf, but escape replicative senescence with reduced expression of p53, p21
Cip1/Waf1 and other p53 downstream proteins [95] .
Zbtb7a-null MEFs become senescent prematurely because of the upregulation of Arf expression, because senescence can be overcome by mutation of Arf [96] .
SENESCENCE AND AGING IN HUMANS AND MICE
Cellular senescence appears to be related to organism aging. Cellular senescence involves processes that include telomere shortening, accumulation of DNA damage, and activation of the p16 Ink4a /Arf locus. The contributions of these factors to senescence seem to differ in humans and mice. Cultured mouse fibroblasts undergo senescence even when they have long telomeres and high telomerase activity. Senescence is abrogated by the loss of the p16 Ink4a /Arf locus [82] . In human cell cultures, the ectopic expression of telomerase is sufficient to overcome senescence by maintaining the length of the telomeres [97] . In mice, the maintenance of telomere length is important because telomerase deficiency shortens their lifespan and leads to premature aging [98] [99] [100] . The age-dependent accumulation of INK4A has been observed in human kidneys and skin [101, 102] , as well as in the majority of mouse tissues [100, 103] . In oncogene-induced senescence, there is in vivo evidence that Arf is the important factor in the activation of p53 tumor suppression [103, 104] . However, another study has shown that components of the DNA-damage signaling cascade, including ataxia telangiectasia mutated (Atm) and Chk2 proteins, are crucial for activation of p53 in response to oncogenic signals [105] [106] [107] . These differences between humans and mice could be attributable to species specificity and/or experimental conditions. Cellular senescence appears to be related to organism aging because the same processes appear to be involved. Genetic variants of the p16 Ink4a /Arf locus are linked to age-associated disorders, such as general frailty, heart failure, and type 2 diabetes [108] [109] [110] [111] [112] [113] . Mutations in telomerase or proteins that affect telomerase activity are linked to premature human aging syndromes, including congenital dyskeratosis and aplastic anemia [114] . There are increases in DNA mutations, DNA oxidation, and chromosome loss during organism aging. It seems reasonable to assume that all three factors, activation of the p16
Ink4a
/Arf locus, telomere shortening, and accumulation of DNA damage, have cooperative effects on aging in physiological situations. Understanding the mechanisms of cellular senescence is currently of wide interest and it is important that we identify new components of this process, such as JDP2.
HISTONE CHAPERONES
Activation and repression of gene expression at the chromatin level are subject to regulation by enzymes that reorganize and rearrange the chromatin template [10] . Both ATP-dependent chromatin-remodeling complexes and histone chaperones mediate an increase in the accessibility of promoters to transcription factors, and facilitate histone-exchange reactions within the nucleosomes [115, 116] . Histone-exchange reactions are important because they allow histone variants to be incorporated into nucleosomal arrays independently of the synthesis of DNA. The deposition of histone variants, such as H2A.Z, has a major impact on gene expression because these variants are known to be localized within specific transcriptional domains and within the heterochromatin [117, 118] .
In yeast cells, transcription is accompanied by the disruption of nucleosomal structures, which suggests an inverse correlation between gene activation and nucleosome assembly [119] . Although sliding mechanisms have been proposed to explain this phenomenon, experimental evidence suggests that nucleosome displacement can occur via disassembly of the nucleosome that involves the removal of histones [7] [8] [9] [10] . Analysis of the expression of an inducible gene for interleukin-2 also suggests the removal of histones from the promoter of this mammalian gene upon activation of transcription [120] . Histone chaperones are key players in the removal of histones in this context [121] . For example, nucleosome disassembly is mediated by anti-silencing function 1 (ASF1)/CCG-1-interacting factor (CIA), which is a histone chaperone and is essential for activation of gene transcription [121] . During gene repression, however, ASF1/CIA-independent reassembly of nucleosomes is observed in the same system [121] . Thus regulation of transcription includes the disassembly of nucleosomes for gene activation, and deposition of histone nucleosomes and assembly of nucleosomes for establishment of the basal or repressed state. Some histone chaperones function with components of several chromatin-related complexes, which include HATs [122] , HDACs [123] , and the ATP-dependent chromatin-remodeling complex [124] . Thus, acting in concert with other chromatin-related factors, histone chaperones play important roles in nuclear events that involve chromatin templates.
The histone chaperone known as nucleosomeassembly protein-1 (NAP-1) acts autonomously to exchange H2A-H2B dimers and to incorporate histone variants into intact nucleosomes [118, 125] . In vitro, NAP-1 has been shown to facilitate the binding of transcription factors to sites of nucleosomes, and this process requires the disassembly of nucleosomes [126] . NAP-1 also associates with the co-activator p300/CBP, with the resultant enhancement of p300-mediated activation of transcription [127] . NAP-1 is, to date, the best characterized histone-chaperone protein. The crystal structure of NAP-1 reveals that it includes a long α helix, which is responsible for homodimerization, and a four-stranded antiparallel β sheet, as do other histone-chaperone proteins [128] .
A protein that is involved in the sorting of proteins to vacuoles, designated Vps75, has been identified as a member of the NAP-1 family of histone-chaperone proteins in yeast [129] . It has a preference for (H3-H4) 2 tetramers and forms a complex with Rtt109 (a protein that participates in the regulation of Ty1 transposition) [130] . The complex is composed of acetylated-only free histone H3 in vitro, with no detectable activity towards nucleosomal H3 [131] . Thus we speculate that acetylation of lysine 56 of H3 is, at least in part, regulated by the inability of Rtt109-Vsp75 HAT complexes to acetylate nucleosomal H3 during the G 2 /M phase of the cell cycle [131] . During DNA replication, Rtt109 acetylates lysine 56 of histone H3 to promote genome stability [132, 133] in the premeiotic and meiotic S phases, and its activity is detectable when DNA is damaged [134, 135] . Efficient acetylation by Rtt109 requires a histone-chaperone protein, either ASF1 or Vsp75, but not chromatin-assembly factor-1 (CAF-1) [130] . By contrast, chromatin-assembly factor-1 and Rtt106p mediate the formation of heterochromatin by contributing to the spreading of Sir protein during the early stages of heterochromatin formation [136] .
English et al [137] have determined the crystal structure of a histone chaperone (ASF1/CIA) that binds to a histone H3-H4 heterodimer. ASF1/CIA physically blocks formation of (H3-H4) 2 tetramers and the C terminus of H4 undergoes a dramatic conformational change upon binding to ASF1. Within nucleosomes, the C terminus of H4 (residues 93-102) makes contact with H2A and is bound within the nucleosome [5] . During nucleosome disassembly, H2A-H2B dimers are removed by other histone chaperones and ATPdependent remodeling complexes, which exposes the C terminus of H4 in the tetrasome complex [5, 137, 138] .
ASF1 recognizes and captures the C terminus of H4 in the tetrasome, which is the site of complex changes in the conformation of the H4 C terminus in the ASF-(H3-H4) 2 complex. ASF1 then dissociates the H3-H4 dimer that is bound to ASF1. Other histone chaperones and chromatin-remodeling complexes might also be involved in the dissociation of the (H3-H4) 2 tetramer. The reverse relationship might be a feature of nucleosome assembly. The histone (H3-H4) 2 tetramer-disrupting activity of ASF1/CIA and the crystal structure of the ASF1/CIA-histone H3-H4 dimer complex provide some insight into the mechanisms of both the assembly and disassembly of nucleosomes.
Recently Muto et al [139] have reported a comparison of the crystal structures of template-activating factor (TAF)-1β and NAP-1. They have found that the two proteins are folded similarly, with the exception of the inserted helix. These backbone helices are shaped differently, and the relative disposition of each backbone helix and the "earmuff" domains between the two proteins differ significantly. The histone-chaperone activity is associated with the lower surface of the earmuff domains [139] . Akai et al have reported that the molecular complex between CIA/ASF-1 and the double bromodomain complex plays a key role in sitespecific histone eviction at the active promoter [140] .
DOMAINS THAT INTERACT WITH CHROMATIN
We have defined five groups of nucleosome-binding domains: bromodomains, chromodomains, WD40 repeats, tudor domains, and PHD fingers. Bromodomains recognize and bind acetylated lysine residues [141, 142] . For example, general control nonrepressive 5 (Gcn5) contains a bromodomain that is important for the binding, recognition and retention of SAGA on acetylated promoter nucleosomes [143] . Chromodomains bind methylated lysine tails specifically. The chromodomain of heterochromatin protein 1 binds methylated lysine 9 of H3, whereas the chromodomain of Polycomb binds methylated lysine 27 of H3 [144] [145] [146] [147] [148] . The chromodomain of Eaf3, a protein subunit shared by the HAT complex NuA4 and the HDAC complex Rpd3S, is important for the recognition of and binding to methylated lysine 36 of H3 [149] [150] [151] . Loss of this binding leads to increased acetylation in transcribed regions and the formation of spurious transcripts that are initiated within open reading frames [151] . Unlike acetylation, methylation can occur once, twice or three times, generating mono-, di-and trimethylated histones, and the protein domains that bind to methylated histones associate differentially with histones with varying levels of methylation. The WD-domain-containing protein WDR5 binds dimethylated lysine 4 of H3 preferentially in vitro, in addition to associating with a complex that also has HAT activity [152] . The crystal structure that demonstrates recognition by WDR5 of lysine 4 dimethylated H3 shows how the WDR repeats distinguish between the di-and trimethylated lysine 4 residues of H3 [153, 154] . Both so-called tudor domains and WD-domain-containing proteins are present in various HAT complexes, including SAGA. Recently, a plant homeodomain, the PHD finger, which has been found in a number of proteins in various HAT complexes, has been shown to bind to trimethylated lysine 4 of H3 [155] [156] [157] . An emerging theme for these various chromatin-binding domains is that they are often associated with enzymes that modify or alter chromatin, such as Eaf3 and WDR5 [157, 158] , in the case of Gcn5 HAT [149] . To understand fully the functions of these domains, we need to study their locations within relevant protein complexes.
INTERACTION OF TRANSCRIPTION FACTORS WITH HISTONES AND NUCLEOSOMES
Transcription factor IIIA (TFIIIA) is a 40-kDa protein, with nine zinc finger domains, that binds specifically to the internal promoter of the gene for 5S RNA and to the N-terminal tail domains of histones H3 and H4, but not those of H2A and/or H2B, and directly modulates its ability to bind nucleosomal DNA [159, 160] .
A new class of HAT-regulatory proteins has been identified. These proteins block HAT activity via binding to and masking of the histone themselves. This class includes the subunits of the inhibitor of histone acetyltransferase (INHAT) complex; TAF-1α, TAF-1β, and pp32, as well as ataxin 3; silencing mediator or retinoid receptor corepressor/nuclear hormone receptor corepressor; and proline-, glutamate-and leucinerich protein 1 [161] [162] [163] [164] [165] [166] [167] . Thanatos-associated protein 7 is known to associate with TAF-1β and to repress transcription by inhibition of histone acetylation [168, 169] . This is a novel co-repressor that activates INHAT binds directly to nucleosomes and core histones, and prevents acetylation by HATs, thus acting as a bona fide INHAT [170] . PU.1, a member of the Ets family of oncoproteins, inhibits CBP-mediated acetylation of GATA-binding protein-1 (GATA-1) and erythroid Krüppel-like factor 2 (EKLF2), as well as of histones, and disrupts acetylation-dependent transcriptional events [171] . Moreover, PU.1 recruits the retinoblastoma tumor-suppressor protein, a histone methyltransferase Suv39H, and heterochromatin protein 1 [172] . Similarly, proliferating cell nuclear antigen binds to p300 to inhibit its HAT activity in vitro and to block HAT-dependent transcription in vivo [173] . TAF-1β and pp32 have also been shown to interact with estrogen receptor-α (ER-α), to inhibit the ERα-mediated activation of transcription, and activation of ER-α acetylation by p300 [166, 167] . Moreover, TAF-1β also interacts with the Sp-1 transcription factor and with KLF5, negatively regulating binding to DNA and activation of transcription by these factors [174, 175] . Transcription factor nuclear factor-κB p50 can accommodate distorted, bent DNA within the nucleosome [176] , whereas the DNA-binding domain of c-Myb binds to the N-terminal tails of H3 and H3.3, and binding of c-Myb facilitates acetylation of histone tails [177] . Moreover, kinetochore-null protein 2, which has a c-Myb-like DNA-binding domain is specifically required for loading of centromere-specific variants of histone H3 (centromere protein A) in nematodes and mammalian cells [178] . The recruitment of repressive macroH2A nucleosomes requires direct interactions between ATF-2 bound to the nearby AP-1 site and macroH2A and it is regulated by DNAinduced protein allostery [179] . Thus the abovementioned sequence-specific DNA-binding factors might regulate transcription either via histone cores or tails, as well as via the structure of nucleosomes, in conjunction with other proteins that bind to the chromatin.
JDP2 REGULATES AP-1-MEDIATED ACTIVATION OF TRANSCRIPTION
JDP2 has been identified as a binding partner of c-Jun in yeast two-hybrid screening experiments, based on the recruitment of the SOS system [180] . JDP2 forms heterodimers with c-Jun and represses AP-1-mediated activation of transcription [180] . Similarly, JDP2 was isolated by yeast two-hybrid screening with activation transcription factor-2 (ATF-2) as the "bait" [181] . JDP2 has also been shown to associate with the CAAT/enhancer-binding protein-γ [182] and the progesterone receptor [183] . JDP2 is constitutively expressed in many cell lines and represses the transcriptional activity of AP-1 [184] . Moreover, JDP2 is rapidly phosphorylated at threonine residue 148 when cells are exposed to UV irradiation, oxidative stress, or inhibitor-induced depressed levels of translation by JNK [185] . Although a novel JNK-docking domain is necessary for the p38-mediated phosphorylation of JDP2 at threonine residue 148, this domain is not sufficient for this process [186] . JDP2 binds to both cAMPand TRE-response elements on DNA as a homodimer, and as a heterodimer with ATF-2 and members of the Jun family, respectively [180, 181] . JDP2 inhibits UVinduced apoptosis by suppressing the transcription of the p53 gene [187] . Given the roles of AP-1 in cellular transformation and the reported repression of Junand ATF-2-mediated transcription by JDP2, we have demonstrated that JDP2 inhibits the oncogenic transformation of chicken embryonic fibroblasts [188] . JDP2 also modulates the expression of cyclin D1 and p21, which have opposing effects on cell-cycle progression. JDP2 interferes with the progression of the cell cycle by reducing the levels of cyclin D1 and at the same time, increases the expression of p21 [189, 190] . The forced expression of JDP2 promotes the myogenic differentiation of C2C12 cells, which is accompanied by the formation of C2 myotubes and the strong expression of major myogenic markers. Moreover, the ectopic expression of JDP2 in rhabdomyosarcoma cells induces incomplete myogenesis and the incomplete formation of myotubes. These cells become committed to differentiation via the p38-MAPK pathway [190] . A similar enhancement of cell differentiation has been reported during induction of osteoclast formation by the receptor activator of the nuclear factor κB ligand (RANKL) [191] . Unlike other members of the AP-1 family, the levels of JDP2 remain constant in response to a large variety of stimuli, such as UV, irradiation, and retinoic acid (RA), which affect the levels of other factors involved in cell-cycle control. The induction of JDP2 expression has only been observed during the differentiation of F9 cells to muscle cells and osteoclasts. Therefore, JDP2 might provide a threshold for exit from the cell cycle and a commitment to differentiation. Further studies on regulation of the cell cycle and differentiation of cells induced by JDP2 should be instructive. It is also interesting that JDP2 is one of the candidate oncoproteins that collaborate in the oncogenesis associated with the loss of p27, as a result of insertional mutations [192] . Recent studies of tumor cells have demonstrated that JDP2 is a tumor suppressor [193] . We have also found that JDP2 is a repressor of activation of transcription via AP-1, and a negative regulator of RA-induced differentiation of mouse embryonic F9 cells [194, 195] .
JDP2 INHIBITS HAT ACTIVITY
We have reported previously that JDP2 represses the transactivation mediated by p300 [195] . Both p300 and ATF-2 have HAT activity [196, 197] . It was recently shown that p300 acetylates ATF-2 protein in vitro at lysine residues 374 and 357 and that ATF-2 is essential for the acetylation of histones H4 and H2B in vivo [198, 199] . We found that acetylation by p300 is inhibited in a dose-dependent manner by JDP2, when added exogenously. We also found that JDP2 was not acetylated by p300 under our experimental conditions. The inhibitory effect of JDP2 on histone acetylation is induced by p300, CREB binding protein (CBP), p300/CBP associated factor (PCAF), and Gcn5. Overexpression of JDP2 apparently represses RA-induced acetylation of lysine residues 8 and 16 of histones H4 and H3.
JDP2 HAS INTRINSIC NUCLEOSOME-ASSEMBLY ACTIVITY IN VITRO
The TAF-Iβ protein, which is a component of the INHAT complex identified by Seo et al [162, 163] , is a histone chaperone that binds directly to core histones and facilitates the assembly of nucleosomes in vitro. JDP2 interacts directly with all the core histones tested and inhibits the p300-mediated acetylation of those histones. To our surprise, JDP2 also introduces supercoils into circular DNA in the presence of core histones, to levels similar to those observed for yeast CCG1-interacting factor 1 protein (yCia1p) and CIA1. Therefore, JDP2 appears to have significant histone chaperone activity in vitro [195] . We have also shown that the HAT-inhibitory activity of JDP2 is involved, to some extent, in the repression of transcription by JDP2, whereas the maximal capacity of JDP2 to suppress the RA-mediated activation of the c-Jun promoter ( Figure 1 ) [195; Figure 1 ] and to suppress adipocyte differentiation [200] requires recruitment of HDACs. [76; Figure 2 ]. There is some evidence that Jdp2 acts as a tumor suppressor: Jdp2 inhibits the Rasdependent transformation of NIH3T3 cells [193] and Jdp2 gene disruptions are often found in lymphomas induced by insertional mutagenesis caused by the Moloney murine leukemia virus in MYC/Runx2 transgenic mice [201] . Here, we suggest that Jdp2 not only inhibits the transformation of cells, but also plays a role in the induction of cell senescence as well as cell cycle arrest [202] . These functions of JDP2 might be important for its role in inhibiting tumor formation. Our findings also provide new insights into the molecular mechanisms by which senescence is induced in the context of the epigenetic regulation of the p16 Ink4a /Arf locus.
JDP2 REGULATES REPLICATIVE SENESCENCE
CONCLUDING REMARKS
Like differentiation and tumorigenesis, senescence is associated with dynamic changes in gene expression, which are regulated by chromatin remodeling. Here, we have shown that the expression of p16 Ink4a and
Arf is upregulated in response to accumulating environmental stresses, oncogenic signaling, and DNAdamaging signals, and that they in turn induce irreversible cell-cycle arrest by activating the Rb and p53 pathways, respectively. The expression of p16
Ink4a
and Arf is epigenetically regulated by PRC1 and PRC2, which associate with these loci, methylate histone H3 in young cells, and dissociate in aged and senescent cells. Several factors that upregulate or downregulate the expression of the p16 Ink4a /Arf locus have been reported. It is now important to establish how these different factors regulate senescence. Do they affect only euchromatin or do they also regulate heterochromatin? Do they modify the chromatin structure by recruiting HDACs, HATs, histone methyltransferases, histone chaperones, and/or other molecules? Addressing these precise functions in the context of epigenesis should help us to understand how senescence and, in a broader context, aging, are regulated.
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